{"id":804282,"date":"2026-03-17T04:08:13","date_gmt":"2026-03-17T04:08:13","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/804282\/"},"modified":"2026-03-17T04:08:13","modified_gmt":"2026-03-17T04:08:13","slug":"la-securite-des-vaccins-a-arn-messager-confirmee-apres-cinq-ans-denquete","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/804282\/","title":{"rendered":"La s\u00e9curit\u00e9 des vaccins \u00e0 ARN messager confirm\u00e9e apr\u00e8s cinq ans d\u2019enqu\u00eate"},"content":{"rendered":"

L\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament (ANSM) a annonc\u00e9, lundi, la fin de son enqu\u00eate nationale de pharmacovigilance sur les vaccins anti-Covid \u00e0 ARN messager<\/a>, apr\u00e8s cinq ann\u00e9es de suivi renforc\u00e9. L\u2019autorit\u00e9 sanitaire pr\u00e9cise toutefois que la surveillance ne s\u2019arr\u00eate pas\u00a0: les signalements continueront d\u2019\u00eatre analys\u00e9s par les centres r\u00e9gionaux de pharmacovigilance. Les donn\u00e9es les plus r\u00e9centes concernant les vaccins Comirnaty (Pfizer-BioNTech<\/a>) et Spikevax (Moderna<\/a>) \u00ab\u00a0confirment une nouvelle fois que ces vaccins sont s\u00fbrs\u00a0\u00bb, selon l\u2019agence.<\/p>\n

Les deux rapports couvrant la p\u00e9riode de f\u00e9vrier\u00a02024 \u00e0 juin\u00a02025 n\u2019ont identifi\u00e9 aucun nouveau signal de s\u00e9curit\u00e9. Pour Comirnaty, l\u2019analyse de 21 cas d\u2019effets ind\u00e9sirables potentiels jug\u00e9s \u00ab\u00a0marquants\u00a0\u00bb n\u2019a montr\u00e9 qu\u2019\u00ab\u00a0aucun lien avec la vaccination<\/a> n\u2019a \u00e9t\u00e9 \u00e9tabli\u00a0\u00bb. Les investigations ont notamment concern\u00e9 des cas d\u2019occlusion de la veine centrale r\u00e9tinienne, d\u2019uv\u00e9ite, de syndrome de tachycardie orthostatique posturale, d\u2019enc\u00e9phalomy\u00e9lite myalgique, de syndrome de fatigue chronique, de HELLP syndrome ou encore de scl\u00e9rose lat\u00e9rale amyotrophique (SLA).<\/p>\n

Pas de hausse de mortalit\u00e9 en France<\/p>\n

Des conclusions similaires ressortent pour Spikevax. L\u2019\u00e9tude de cinq cas marquants n\u2019a pas permis d\u2019associer la vaccination aux pathologies observ\u00e9es, qu\u2019il s\u2019agisse de deux cas de SLA, d\u2019un cas de dermatomyosite ou de signalements de syndrome de fatigue chronique. L\u2019ANSM souligne qu\u2019apr\u00e8s cinq ans de suivi, elle dispose d\u00e9sormais \u00ab\u00a0d\u2019un recul sans pr\u00e9c\u00e9dent (des dizaines de rapports d\u2019expertise nationale r\u00e9alis\u00e9s depuis le d\u00e9but de la vaccination, plus de 160\u00a0millions de doses administr\u00e9es en France et des milliards de doses dans le monde) ainsi que l\u2019absence de nouveaux signaux de s\u00e9curit\u00e9\u00a0\u00bb.<\/p>\n

Notre dossier Sant\u00e9<\/a><\/p>\n

L\u2019agence pr\u00e9cise n\u00e9anmoins que les vaccins<\/a> continueront d\u2019\u00eatre suivis et \u00ab\u00a0resteront surveill\u00e9s de mani\u00e8re \u00e9troite\u00a0\u00bb. Elle rappelle \u00e9galement qu\u2019une \u00e9tude publi\u00e9e en d\u00e9cembre dans la revue Jama Network Open par des chercheurs d\u2019Epi-Phare (structure r\u00e9unissant l\u2019ANSM et l\u2019Assurance maladie<\/a>) indique que les vaccins anti-Covid n\u2019ont pas entra\u00een\u00e9 de hausse de la mortalit\u00e9 en France depuis leur introduction au d\u00e9but des ann\u00e9es\u00a02020, malgr\u00e9 les affirmations relay\u00e9es dans certains milieux vaccinosceptiques<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"L\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament (ANSM) a annonc\u00e9, lundi, la fin de son enqu\u00eate nationale de pharmacovigilance…\n","protected":false},"author":2,"featured_media":804283,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[10],"tags":[47,732,4357,7078,1011,27,72,48631,55773,71,773,48881,148],"class_list":["post-804282","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sante","tag-actualite","tag-assurance-maladie","tag-covid-19","tag-etude","tag-fr","tag-france","tag-health","tag-moderna","tag-pfizer-biontech","tag-sante","tag-vaccin","tag-vaccin-anti-covid","tag-vaccination"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/116242553687766803","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/804282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=804282"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/804282\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/804283"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=804282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=804282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=804282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}